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ABSTRACT
Expression profiling experiments usually provide a
static snapshot of messenger RNA (mRNA) levels.
Improved understanding of the dynamics of mRNA
synthesis and degradation will aid the develop-
ment of sound bioinformatic models for control of
gene expression. We studied mRNA stability in
proliferating and differentiated myogenic cells
using whole-genome exon arrays and reported the
decay rates (half life) for 7000 mRNAs. We showed
that the stability of many mRNAs strongly depends
on the differentiation status and contributes to dif-
ferences in abundance of these mRNAs. In addition,
alternative splicing turns out to be coupled to mRNA
degradation. Although different splice forms may be
produced at comparable levels, their relative abun-
dance is partly determined by their different
stabilities in proliferating and differentiated cells.
Where the 30-untranslated region (30-UTR) was pre-
viously thought to contain most RNA stabilizing and
destabilizing elements, we showed that this also
holds for transcript isoforms sharing the same
30-UTR. There are two splice variants in Itga7, of
which the isoform with an extra internal exon is
highly stable in differentiated cells but preferentially
degraded in the cytoplasm of proliferating cells. In
conclusion, control of stability and degradation
emerge as important determinants for differential
expression of mRNA transcripts and splice variants.
INTRODUCTION
Although the abundance of messenger RNAs (mRNAs) in
the cell is the net result of mRNA synthesis and
degradation, expression proﬁling experiments usually
take a snapshot of the mRNA levels in the cell and do
not capture the dynamics of mRNA synthesis and break-
down. This lack of information on the dynamic compo-
nent of the regulation of mRNA levels limits biological
investigations in general and proper modeling of tran-
scriptional networks in systems biology approaches in
particular. When mRNA synthesis is shut down complete-
ly, the effect may be immediate for very short-lived
mRNAs but only manifest after hours or days for
mRNAs with long half lives. The current study ﬁlls in
part of this gap and surveys mRNA degradation rates
during muscle differentiation on a genome-wide scale.
With the availability of these data, the genetic network
orchestrating muscle differentiation can be revised and
improved.
From the results of previous genome-wide analyses of
mRNA degradation rates, we know that there are large
differences between the stabilities of individual mRNAs,
and that mRNA stability is strongly related to the molecu-
lar function of the encoded protein (1–8). However, the
mechanisms underlying differential stability of transcripts
remain poorly understood. MicroRNA (miRNA)-
mediated mRNA degradation emerged as an important
controlling factor for mRNA half life. Earlier research
also characterized a plethora of RNA binding proteins
that may affect mRNA stability (9). Recent studies in
differentiating embryonic stem cells (7) and T-cells (6)
demonstrated that mRNA stability may be affected by
the cell’s biological state. Furthermore, an important
subgroup of transcripts use alternative polyadenylation
sites depending on the differentiation status (10). This
results in 30-untranslated regions (30-UTRs) with variable
lengths and probably contributes to the differential stabil-
ity of these transcripts (10). The deciding factors
determining the choice for shorter or longer 30-UTRs are
currently unknown.
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We were interested in the control of decay rates during
myogenic differentiation and studied proliferating and
differentiated myogenic C2C12 cells, a well-established
system to study differentiation of muscle cells. Cells were
treated with actinomycin D to arrest de novo RNA synthe-
sis, with sampling at short time intervals. We used
Affymetrix whole-genome exon arrays covering all
known and predicted exons. Where previous genome-wide
studies determined expression levels and stability of the
30-ends of transcripts, these arrays allowed us to assess ex-
pression level per exon and thereby, for the ﬁrst time, the
effect of alternative splicing on mRNA decay rates. Our
results demonstrated that changes in mRNA abundance
during differentiation of muscle cells are correlated with
changes in decay rates and that the ratios of speciﬁc splice
variants are controlled at the level of mRNA stability.
MATERIALS AND METHODS
Cell culture, RNA isolation, microarray hybridization
C2C12 cells were grown in proliferation medium
[Dulbecco’s modiEed Eagle’s medium (DMEM) with
10% fetal bovine serum (FBS), 2% Glutamax, 1%
glucose and penicillin/streptomycin]. Myogenic differenti-
ation was induced by shifting to differentiation medium
(DMEM with 2% FBS, 2% Glutamax, 1% glucose and
penicillin/streptomycin). C2C12 cells were maintained in
differentiation medium for 8 days, when long and
multinucleated myotubes had formed. Cultures of
proliferating and differentiated C2C12 muscle cells in
6-well dishes containing 3-ml medium were treated with
5 mg/ml actinomycin D to arrest the transcription machin-
ery. At seven different time points after addition of
actinomycin D (0, 10, 20, 30, 60, 150, 480min), cells
were lysed and RNA was isolated with the Machery
Nagel Nucleospin RNAII Kit. There was no notable
decrease in cell viability within this time period. The ex-
periment was performed in duplicate. After depletion of
ribosomal RNAs, mRNA was reverse transcribed with
random primers containing a T7 tag, and labeled with
biotin during the T7 RNA ampliﬁcation (which retains
strand speciﬁcity), according to standard Affymetrix
protocols. Equal amounts of ampliﬁed RNA were
hybridized to 28 Affymetrix Mouse Exon v1 arrays
[7 time points 2 replicates 2 conditions (proliferating/
differentiated)].
Affymetrix exon arrays
Affymetrix Mouse Exon v1 arrays contain 1 236 087
non-control probe sets. Most probe sets consist of four
probes and the intensity value of each probe set is the
robust mean of the individual probe sets. Most exons
are covered by at least one probe set. There is a subset
of exons, called core exons, which represent all the exons
for which there is substantial experimental proof for their
existence. Next to the core set, the array covers a huge set
of computationally predicted exons. The intensities of
probe sets in most of these latter exons (in our experiment
91 versus 51% for core exons) are not above background,
and these have not been considered in the analysis
described here. Data from these arrays can be analyzed
at the exon or the gene level. The presented gene level
summarization, giving only one expression value per
gene, considers the intensities of probes in core exons only.
Data analysis—normalization
In our experimental set-up, normalization is not straight-
forward, since an important assumption underlying
standard normalization procedures, equality of the total
amount of mRNA under all conditions studied, is
violated. Despite the decrease in the total amount of
mRNA in the cell at later time points, equal amounts of
RNA have been hybridized to the chips. This means that
the samples from the later time points will be enriched for
stable transcripts and depleted for fast decaying tran-
scripts. We tried to use spike-in RNAs to correct for the
differences in input RNA but this was not successful due
to the low number of spike-in RNAs used. Thus the only
alternative was to use a standard normalization method,
with the intensities of more stable transcripts increasing at
later time points.
The median polish summarization method [as imple-
mented in RMA (11)] was applied to summarize the
intensities of probes in a probe set and probes in a gene.
VSN [variance stabilization and normalization (12)] was
used for normalization. VSN and RMA normalization
generated similar values in the high intensity range. In
the lower intensity range, the variance stabilizing
properties of the VSN algorithm corrects for noise-
induced artiﬁcially inﬂated differences between arrays in
near-background reads. As an additional advantage, the
VSN data are on a natural logarithm scale compatible
with our exponential decay model, whereas the RMA
data are on a log2 scale. Since the arrays contain many
negative and positive control spots, the effect of removing
those before the normalization was investigated. This had
no effect on the normalization of the non-control spots.
As a threshold for background intensity levels, we used the
mean+2 SD of around 4000 negative control probes on
the array.
All normalization and subsequent data analysis was
performed in the statistical programming language R (13).
Raw and normalized data have been submitted to GEO
and are available under series GSE14387.
Data analysis—model ﬁt
To model decay rates, a standard linear model (1) was
ﬁtted with normalized intensity Y of each probe set j as
dependent variable and time as independent, continuous
variable.
Yi ¼ j+j  time+"j ð1Þ
where time is a vector (0, 10, 20, 30, 60, 150, 480); aj rep-
resents the intercept (estimated expression level at t=0);
bj represents the slope (negative of the decay constant).
The appropriateness of this model is discussed in the
Supplementary Methods and in the caption of
Supplementary Figure S1. Replicate time points were in-
dependent data points in the model. Two separate models
were ﬁt for the proliferating and differentiated cells. Decay
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constants were said to be signiﬁcantly different between
proliferating and differentiated cells when there was no
overlap between their 95% conﬁdence intervals (as
determined from the standard error on , and given the
t-distribution and 12 degrees of freedom). Decay constants
for entire transcripts were calculated using the exact same
model, but after summarizing core probe sets in a tran-
script into a single expression value by RMA. The half life
is given by –ln(2)/.
For identiﬁcation of probe sets with a behavior different
from the other probe sets in the gene (possible alternative
splicing events), we considered the mixed effect model (2)
(nlme package; lme function in R), where time is a con-
tinuous variable and treated as a ﬁxed effect, where the
probe sets were considered as random effects and where
we included an interaction term between the probe sets
and the differentiation status. In formula form (14):
Yijk¼  time+bj+bjk+"ijk ð2Þ
where bj  N (0, s12), bjk  N (0, s22), "ijk  N (0, s2) and
where Yijk represents normalized intensity of probe set j
(j=3, . . . , n probe sets in the gene) with differentiation
status k (k=1, 2) in gene i; time represents time vector
(0, 10, 20, 30, 60, 150, 480);  represents ﬁxed effect; bj
represents random intercept; bjk represents the interaction
between the probe set and differentiation status and "ijk
represents error term.
Data analysis—annotation and visualization
The R package Xmap (15), interfacing to a local Ensembl
install (mouse release 47; NCBI genome build 37) was used
for annotation and visualization of the exon-level data.
Quantitative PCR analysis
Quantitative polymerase chain reaction (qPCR) analysis
with SYBR-Green detection was performed as described
earlier (16). Bgn was used in the RNA decay studies as a
reference gene to correct for differences in input cDNA.
Bgn was found to be extremely stable and did not change
signiﬁcantly in Ct value over the time period analyzed.
Gapdh was used as a reference gene for the nuclear
versus cytoplasmic comparison.
30-RACE
To determine the polyadenylation sites in the Itga7 tran-
script, we performed 30-RACE (rapid ampliﬁcation of
cDNA ends). We performed a reverse transcription
(RevertAid RNaseH-M-MuLV, MBI-Fermentas) on
500 ng of total RNA starting at the polyA site with an
anchored primer oligo-dT primer (sequence: GCTCGCG
AGCGCGTTTAAACGCGCACGCGTTTTTTTTTTTT
TTTTTTVN). Subsequently, we performed two rounds of
PCR [30 cycles, Faststart Taq (Roche)]. The forward
primer was designed in exon 22 (sequence: CTGTTAGT
CCTGGCCTTGCT); the sequence of the reverse primer
in the ﬁrst round was GCTCGCGAGCGCGTTTAAAC,
whereas the sequence of the reverse primer in the second
round of nested PCR was GCGTTTAAACGCGCACGC
GT. Bands were excised from agarose gel and sequenced
on an ABI-3700 sequencer.
Isolation of nuclei
Cells were scraped in phosphate buffered saline and
pelleted by centrifugation for 5min at 1500g. The cells
were resuspended in cold lysis buffer (10mM Tris–HCl
pH 7.4, 3mM MgCl2, 10mM NaCl, 1mM EDTA) and
pelleted by centrifugation for 5min at 1500g. After resus-
pending in lysis buffer including 0.5% (v/v) Triton X-100,
cells were disrupted in a Dounce homogenizer with 4 10
strokes of the pestle. Nuclei were pelleted by centrifuga-
tion for 2 5min at 1500g and washed with lysis buffer
(without Triton X-100). Nuclei were puriﬁed by sucrose
gradient centrifugation. To this end, a centrifuge tube was
ﬁlled with 4ml of high sucrose buffer (2 M sucrose, 5mM
MgAc, 0.1mM EDTA, 10mM Tris–HCl pH 8.0, 1mM
DTT) and nuclei were added after mixing with 4.4ml of
low sucrose buffer [0.32 M sucrose, 3mM CaCl2, 2mM
MgAc, 0.1mM EDTA, 10mM Tris–HCl pH 8.0, 1mM
DTT, 0.5% (v/v) Triton X-100], with subsequent centrifu-
gation for 30min at 30 000g in an SW41 rotor. Pellet was
resuspended in 300 ml of storage buffer [50 mM Tris–HCl
pH 8.3, 40% (v/v) glycerol, 2mMMgCl2, 0.1mM EDTA],
aliquotted and snap frozen in liquid nitrogen.
RESULTS
Experimental setting
Cultures of proliferating C2C12 muscle precursor cells
and cultures of C2C12 cells differentiated to elongated
and fused myotubes were treated with actinomycin D to
arrest the transcription machinery. At seven different time
points after addition of actinomycin D (0, 10, 20, 30, 60,
150, 480min), RNA was isolated and hybridized to
Affymetrix Mouse Exon v1 arrays (in duplicate,
28 arrays in total). With the selected time intervals, it is
possible to accurately estimate the degradation rates of
relatively short-lived transcripts. For very stable tran-
scripts (t1/2> 480min) the estimate becomes inaccurate,
but longer incubation times resulted in a signiﬁcant
decrease in cell viability severely complicating the analysis.
To model mRNA degradation, we consider an exponen-
tial decay model. This model becomes linear on the loga-
rithmic scale used to report the normalized exon-array
signals (model 1; see Supplementary Methods and
Supplementary Figure S1 for details on the model and
the goodness-of-ﬁt). The slope in this linear model is the
(negative of the) decay constant, whereas the intercept re-
ﬂects the expression level before addition of actinomycinD.
Estimation of decay rates
All mRNAs decay over time. The normalization method
used (see ‘Materials and Methods’ section), centers the
average slopes around zero (Figure 1A). Thus, stable tran-
scripts appear to have positive slopes relative to the
average, whereas transcripts with fast degradation will
have negative slopes. The relative differences in decay
rates (slow decaying versus fast decaying) can be well
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estimated using this model (Figure 1B, Supplementary
Figure S1 and Supplementary Methods). The maximum
slope for expressed genes is 0.0028 intensity units/minute,
the mean is 0.00042 (median 0.00020), and the
minimum 0.0073. If we assume that the slowest
decaying transcript is stable over the period analyzed, all
slopes would need to be corrected with 0.0028. The half
life is calculated as ln(2)/slope and the shortest half life
we observed is then 69min, the median half life of all ex-
pressed transcripts 231min. This is in a similar range as
reported before for proliferating C2C12 cells (8). The
decay rates determined on the microarrays correlate well
with those measured by quantitative PCR [Figure 2,
Pearson’s correlation coefﬁcient: 0.94 (P=3.2 106)],
in spite of the array data appearing to overestimate the
half life of short-lived transcripts and to underestimate
those of stable transcripts. Relative decay rates for all
genes with detectable expression (6852 in total) are
reported in Supplementary Table S1.
Factors determining mRNA half life
It has been noted that mRNA stability appears to correl-
ate with the cellular function of the encoded proteins
(1–8). To study this correlation in our data we functionally
classiﬁed the most stable and unstable mRNA transcripts
in proliferating and differentiated cells (Table 1). We see a
similar correlation. Stable RNAs code for proteins
involved in cell maintenance and structure, short-lived
RNAs code for proteins involved in regulation of gene
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Figure 2. Correlation of microarray- and quantitative PCR-based degradation rates. For both microarray and qPCR assays, the natural logarithm
of the expression level was plotted against the time after start of actinomycin D treatment and a linear curve was ﬁtted. The slope of this curve is the
negative of the decay constant. The slopes for the Bmp4, Ccng2, Cebpg, Pde4dip-short, Pde4dip-long and Itga7-exon27 genes in proliferating and
differentiated myoblasts measured with qPCR with primers designed in the 30-UTR are plotted on the x-axis, and the slopes measured with
microarray probe sets in the same regions are plotted on the y-axis. The correlation coefﬁcient is the Pearson correlation coefﬁcient.
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Figure 1. Estimated relative decay rates measured on microarrays. Distribution of the slopes (negative of degradation rate constants) (A) and R2
values of the linear model (B) for all probe sets (dashed line) and for probe sets in genes expressed above background (solid line). The majority of
probe sets do not give detectable signals and have very ﬂat (slope near zero) and noisy (low R2 values) decay curves. In contrast, expressed genes
frequently demonstrate more positive or negative slopes, and their decay rate constants can be reliably measured (high R2 values). This is expected
since background signals remain constant over time, thus generating a slope close to zero, whereas true signals tend to increase or decrease,
generating a slope away from zero.
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expression, including histones. RNAs coding for
structural and contractile muscle proteins, which are
only expressed in differentiated cells, appear to be very
stable. Transcripts in the category ‘muscle development’
are either very short- or very long-lived, because
this category contains both regulatory and structural
proteins.
Short mRNAs tend to be less stable than average
(Supplementary Figure S2). The median half lives of
mRNAs consisting of one, two, three exons in
proliferating cells are 172, 189 and 199min, respectively.
This is signiﬁcantly shorter (P 1 105 Kolmogorov–
Smirnov test) than the average half life in proliferating
cells (237min). Similar results were obtained for
differentiated cells. Figure 3 visualizes the statistically sig-
niﬁcant shift to shorter half lives in mRNAs with three,
two or one exons.
There is no correlation between 30-UTR length and
transcript stability (Supplementary Figure S3).
mRNA stability is dependent on the cellular state
We calculated the differences in decay rates between
differentiated and proliferating cells. There were 170
mRNAs displaying signiﬁcant differences in stability
between the two states; 99 of those were more stable in
proliferating cells and 71 were more stable in
differentiated cells (Supplementary Table S1).
Interestingly, many of the mRNAs with differences in sta-
bility were also differentially expressed between the two
conditions. Table 2 summarizes some of the results for
transcripts playing an established role in muscle develop-
ment. Slower degradation in differentiated than in
proliferating cells goes with higher expression levels in
differentiated cells, and vice versa. Myog and Cdkn1a
(p21), two important regulators of differentiation previ-
ously shown to have increased expression and stability
in differentiated cells (17–19) are amongst the genes with
clearly different mRNA degradation rates: The half life of
the Myog mRNA increased from 165min in proliferating
cells to 268min in differentiated cells; the half life of the
Cdkn1a mRNA increased from 138 to 371min. The gen-
erality of these observations is illustrated by the strong
positive correlation obtained after plotting the differences
in gene expression against the differences in decay con-
stants (Figure 4, Pearson’s correlation coefﬁcient: 0.57;
P< 2.2 1016). Thus, control of mRNA stability and
degradation emerges as an important determinant for
the regulation of steady-state mRNA levels.
Relative abundance of splice isoforms is controlled by
mRNA stability
The observation that the cellular state determines the
overall decay rates of transcripts triggered us to investi-
gate the role of mRNA degradation in controlling the
ratio between different splice isoforms. To this end, we
used the mixed effect model (2) to identify genes where
the decay constant of a particular probe set differed more
than 2 SDs from the decay constant of all other probe sets
in the gene. Sixty-nine probe sets met these criteria
(Supplementary Table S2). After further ﬁltering for
Table 1. Functional classiﬁcation of fast and slow decaying transcripts in proliferating and differentiated cells
Fast P-value Slow P-value
Proliferating Regulation of cellular processes 3.7 108 DNA-dependent DNA replication 3.6 104
Establishment and/or maintenance of chromatin architecture 7.1 104
Differentiated Regulation of cellular procesess 4.6 1010 Muscle development 1.1 104
Regulation of transcription 8.3 105 Muscle contraction 7.6 1028
Negative regulation of protein kinase activity 3.1 107
Cell cycle 5.0 105
Development 2.1 107
Muscle development 1.3 104
Gene annotation was derived from Gene Ontology. The biological processes signiﬁcantly overrepresented in the 100 fastest and slowest decaying
transcripts in proliferating and differentiated cells are displayed, together with the P-value from the hypergeometric test used for testing overrepre-
sentation. Given multiple testing issues, P< 1 104 was considered to be signiﬁcant.
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Figure 3. One, two and three exon mRNAs have shorter half lives.
Distribution of slopes (negative of degradation rate constants) for all
mRNAs (dashed line), and mRNAs consisting of one (solid line), two
(dash-dotted line) or three (dotted line) exons. The latter three distri-
butions demonstrate statistically signiﬁcant shifts to the left (shorter
half lives), with Kolmogorov–Smirnov P-values of 4.3 109,
1.3 107 and 1.2 105, for one, two and three exons, respectively.
mRNAs with 4 exons were only marginally different from the overall
distribution (P=0.015). The plot is for proliferating cells only, but the
plot and results for differentiated cells are highly similar.
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probes that show a low intensity across all conditions, we
were left with 39 probe sets in 36 genes meeting our very
stringent criteria. The positions of these probe sets in the
mRNAs were evaluated (Table 3). As expected, we found
10 probe sets in 30-UTRs, the length of which is known to
affect transcript stability (10). The mRNAs include
Ankrd2, Myom2, Itgb1, Cacna1s, Pde4dip and Xirp1,
with a known function in muscle development, highlight-
ing the importance of the shift in 30-UTR usage during
myogenic differentiation. Another 13 probe sets were
located in the 50-UTR and one in the coding part of a
ﬁrst exon. Given the known variability in the use of tran-
scription start sites (20), this implicates that the choice for
a transcription start site and thus the length of the 50-UTR
may inﬂuence the stability of the transcript. A further 15
probe sets were located in internal exons, many of them
known to be subjected to alternative splicing. This dem-
onstrates for the ﬁrst time that transcript isoforms that
differ in just one or two internal exons may differ in sta-
bility. This category includes mRNAs coding for struc-
tural muscle proteins, like Myom1, Myom2, Itga7, Tnnt3
and Atp1a2.
The decay of the transcript isoforms of two mRNAs
was investigated in more detail: Pde4dip representing
one of the mRNAs with differential use of 30-UTRs, and
Itga7, representing one of the mRNAs subject to alterna-
tive splicing of internal exons.
Pde4dip. Pde4dip codes for the protein myomegalin, a
protein associated with the Z-discs of skeletal muscles
(21). In the ENSEMBL database, there are three
annotated transcripts for this gene: a long transcript
(indicated as Pde4dip-long) and a shorter transcript with
an alternative 30-UTR (indicated as Pde4dip-short)
(Figure 5A). The expression levels of all exons are
higher in differentiated than in proliferating cells
(Figure 5A, note that exon expression levels reﬂect the
cumulative expression of all transcripts containing that
exon). Quantitative PCR analysis with primers speciﬁc
for the 30-UTRs of the long and short isoforms
demonstrated that the short isoforms are expressed at
similar levels in differentiated and proliferating cells, but
that the long isoform is 25-fold higher expressed
in differentiated compared with proliferating cells
(Figure 5C). Figure 5B shows that the decay of all exons
except for those unique to the short isoforms is slower in
differentiated than in proliferating cells. In addition, the
exons unique to the long isoform are signiﬁcantly more
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Figure 4. Correlation between differential expression and differences in
decay rates. Correlation of the differences in slopes (per minute)
between differentiated and proliferating cells (y-axis) and differences
in normalized expression levels between differentiating and proliferating
cells (x-axis) for gene level data (Pearson’s correlation: R=0.57).
Transcripts that are higher expressed under differentiating conditions
(right side of the plot) seem to have less negative slopes (upper part of
the plot) and thus to be more stable under differentiating conditions.
Probe set level data give similar results but are more difﬁcult to visu-
alize since the plot contains many more data points.
Table 3. Location of probe sets with aberrant slopes as compared with other probe sets in the gene
Number of
probe sets
Probe set location Genes
14 50-UTR, alternative 50-UTR, or coding part of ﬁrst exon Tbrg4, Foxm1, Casq1, Trim37, Ly75, Casq2, Ezh2, Atp2a1,
Ncapd3, Serpine1, Osbp2, Mamdc2, Bub1b, Mybph
10 30-UTR or alternative 30-UTR Kif20a, Ankrd2, Myom2, Foxo6, Cp, Mcm5, Itgb1, Cacna1s,
Pde4dip, Xirp1
9 Internal exon subject to alternative splicing Adssl1, Myom1a, Itga7a, Pygm, Rbm9, Sec24c, Tnnt3
6 Internal exon not knownb to be subject to alternative splicing Tcfap4, Atp1a2a, Cabc1, Myom2, Mmp15
aTwo probe sets in two different exons affected.
bAccording to Ensembl annotation.
Table 2. Half lives of myogenesis-related genes change during
differentiation
Gene Fold-change
differentiated versus
proliferating cells
Half life
proliferating
cells (min)
Half life
differentiated
cells (min)
Tnc 3.86 444 229
Mbnl3 2.72 342 264
Musk 2.82 246 438
Lrp4 3.29 236 416
Cdkn1a 3.73 138 371
Tnnt2 4.75 242 500
Tmod1 7.23 201 455
Acta1 7.75 322 555
Myog 9.09 165 268
Cacna1s 17.01 229 798
Only genes annotated with ‘muscle development’ in Gene Ontology and
a minimum absolute fold change of two are shown.
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mRNA and the natural logarithm of the ratio (y-axis) of the expression levels of the different exons (x-axis) between differentiated and proliferating
cells, as assayed before actinomycin D treatment. Note: using CAGE-seq (cap analysis gene of expression analyzed by high-throughput sequencing,
investigating transcription start sites) data, we found that the annotation of the ﬁrst exon from ENSMUST00000090750 in ENSEMBL is incorrect
(20), explaining its aberrant behavior. (B) Plot of the decay rates in differentiated (closed symbols) and proliferating (open symbols) cells for the
different probe sets in the Pde4dip gene, ordered from 50 to the 30 end of the gene. Less stable parts of the RNA have more negative slopes.
(C) Relative abundance (arbitrary units; a.b.u) of the short and long transcripts of the Pde4dip gene, as assayed by qPCR with primers in the
two different 30-UTRs. (D) Estimated half lives of the short and long transcripts of the Pde4dip gene, as assayed by qPCR with primers in the two
different 30-UTRs. Error bars reﬂect standard error of the mean.
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Figure 6. Association between RNA degradation and alternative splicing in Itga7. (A) Agarose gel displaying the products of 30-RACE for Itga7
with forward primer in exon 22 in proliferating (P) and differentiated (D) cells and a 200-bp size marker (M). The longer fragment (more abundant
in differentiated cells) contains exon 23, whereas the shorter fragment lacks exon 23. The size difference equals the size of exon 23 (113 bp).
Subsequent sequencing conﬁrmed this and mapped the polyadenylation site for both fragments at the previously identiﬁed and annotated polyA
Continued
Nucleic Acids Research, 2011, Vol. 39, No. 2 563
 at V
rije Universiteit- Library on November 12, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
stable in differentiating than in proliferating cells. qPCR
experiments (Figure 5D) validate the longer half life of the
long isoform in differentiated cells. Thus, the ratio
between the long and the short isoform is regulated, at
least in part, at the level of mRNA degradation, and
depends on the differentiation status of the cells.
Itga7. Itga7 is an example of a gene that codes for differ-
ent transcript isoforms that share the same 30-UTR but
differ in stability. Itga7 codes for integrin a7, a transmem-
brane receptor important for maintaining the link between
the extracellular matrix and the cytoskeleton of the muscle
ﬁber (22,23). Itga7 is known to undergo alternative
splicing, resulting in differences in both the extracellular
(N-terminal) and cytoplasmic (C-terminal) domain. The
splice isoform containing an additional exon (here
indicated as 23, referred to in other publications as tran-
script a7A) is speciﬁc for skeletal muscle and expressed
mainly during myogenic differentiation (24). Since this
exon is out-of-frame, inclusion of this exon gives rise to
a protein with an alternative C-terminal amino acid
sequence, which may activate alternative signaling
cascades. By 30-RACE, with a primer in exon 22, we
demonstrated that the transcripts with or without exon
23 indeed share the same 30-UTR and use the same
polyadenylation site (Figure 6A). As expected, transcripts
containing exon 23 are almost exclusively present in
differentiated cells (Figure 6B and D). Both exon-array
(Figure 6C) and qPCR experiments (Figure 6E) with
primers in exon 23 indicate that transcripts containing
exon 23 are very unstable in proliferating cells.
Moreover, analysis of the nuclear fraction of the mRNA
shows that the splice variant that includes exon 23 is made
in proliferating cells and is more abundant in the nucleus
than in the cytoplasm (Figure 6F and G), and therefore
preferentially degraded in the cytoplasm of the
proliferating cells. This example shows that the stability
of splice variants is actively controlled and dependent on
the differentiation status.
DISCUSSION
We reported around 7000 mRNA half lives in
proliferating and differentiated myoblast cells. Given the
480min time interval analyzed, the estimates for
transcripts with half lives shorter than 480min are more
precise than those for very stable transcripts. The reported
half lives can guide the choice of evaluation time points in
future studies where transcript levels are induced or re-
pressed [with the obvious exception of small interfering
RNA (siRNA) experiments inﬂuencing mRNA degrad-
ation itself]. Knowledge on mRNA half life can be used
in the analysis of gene expression proﬁling studies to
identify genes that are in fact completely shut down,
whereas the data as such only indicate that expression is
slightly reduced. In addition, the data can be used to ﬂag
transcripts or transcript isoforms that can not be valued
since their mRNA half lives exceed the time points
analyzed, or demand special attention due to signiﬁcantly
altered half lives.
Furthermore, we show that transcripts, including
speciﬁc splice variants, with a role in myogenesis and
differential expression between proliferating and
differentiated myoblasts frequently demonstrate different
stabilities in the two states. Transcripts with higher expres-
sion in differentiated than in proliferating cells are more
rapidly degraded in proliferating cells and vice versa. A
cell is in some cases reminiscent of a Dutch auction. When
the clock is down to zero and there appears to be no
demand, the commodities are to be destroyed.
Despite the characterization of a multitude of proteins
and pathways involved in mRNA degradation (9), we are
only beginning to understand the mechanisms that control
the stability and degradation of individual transcripts. The
30-UTR is very important for transcript stability given the
presence of miRNA target sites, AU-rich elements (AREs)
and binding sites for other RNA-binding proteins. Our
observation that decay constants of ﬁrst or last probe
sets in a gene frequently differ (are higher or lower)
from the other probe sets is consistent with the reported
extensive use of differential 30-UTRs (and alternative pro-
moters) depending on the tissue or cellular state
(10,25–27). In differentiating T-cells (10) and in cancer
cells (27), differential expression of transcripts has been
related to alternative 30-UTR (polyadenylation site) use,
resulting in differences in mRNA stability.
It is not yet clear which RNA binding proteins are re-
sponsible for the control of mRNA stability during
myogenic differentiation. The HuR and KSRP can tran-
siently affect the stability of transcripts containing AREs
Figure 6. Continued
site (position 4018 in GenBank entry NM_008398.2). (B) Exon structure of three different transcript isoforms (indicated by their Ensembl transcript
identiﬁer) and the natural logarithm of the ratio (y-axis) of the expression levels of the different exons (x-axis) in the Itga7 gene, as assayed before
actinomycin D treatment. The arrow indicates exon 23, which is preferentially incorporated in transcripts expressed in differentiated myoblasts.
(C) Plot of the decay rates in differentiated (closed symbols) and proliferating (open symbols) cells for the different probe sets in the Itga7gene,
ordered from 50 to the 30 end of the gene. Less stable parts of the RNA have more negative slopes. The arrow indicates the probe in exon 23. The
transcript containing exon 23 is much more stable in differentiated than in proliferating myoblasts. (D) Relative abundance (arbitrary units; a.b.u) of
the different transcripts of the Itga7 gene, as assayed by qPCR with primers in exon 23 (assaying only transcripts that include exon 23), exons 22 and
24 (a combination of transcripts that do and do not include exon 23), and exon 24 (assaying all transcripts), in proliferating (open bars) and
differentiated (closed bars) cells. (E) Estimated half lives of the different transcripts of the Itga7 gene, as assayed by qPCR with the primers described
under (D) in proliferating (open bars) and differentiated (closed bars) cells. Error bars reﬂect standard error of the mean. (F) Melting curves obtained
after qPCR with with forward primer in exon 22 and reverse primer in exon 24 of the Itga7 gene in total (left) and nuclear (right) RNA of
proliferating (top) and differentiated (bottom) cells. Two different PCR products were obtained. The product containing exon 23 melts at a higher
temperature than the product without exon 23. The transcript containing exon 23 is present in the nuclei of proliferating myoblasts but barely
detectable in total RNA (mainly cytoplasmatic). (G) Abundance of the Itga7 transcript containing exon 23 in total and nuclear RNA of proliferating
(left) and differentiated (right cells), as determined by qPCR with forward primer in exon 22 and reverse primer in exon 23. Note the different scales
for the left and right graphs.
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during myogenic differentiation (17–19,28). However,
only a minority of the transcripts with variable decay
rates contain AU-rich elements [ARE motifs, predicted
by the ARED algorithm (29)] in their 30-UTR. From
our digital gene expression studies (20), two members of
the tristetraprolin family of RNA binding protein emerge
as other important candidate factors for differentiation
state-dependent control of mRNA degradation:
ZFP36L1, which has been shown to accelerate degrad-
ation of tumor necrosis factor-alpha (TNF-a), vascular
endothelial growth factor (VEGF) and granulocyte
macrophage-colony stimulating factor (GM-CSF)
(30–32) and ZFP36L2. The former is 10-fold increased
and 3-fold decreased in expression during myogenic dif-
ferentiation. The muscle-speciﬁc RNA binding protein
CUGBP has been shown to stabilize mRNAs by binding
to GU-rich elements in the 30-UTR (8,33). However,
CUGBP shows little variation in expression between
proliferating and differentiated cells and is therefore less
likely to be responsible for the differences in decay rates
observed in proliferating and differentiated myoblasts. In
addition to RNA stabilizing and destabilizing proteins,
also miRNAs and components of the nonsense-mediated
decay machinery have been shown to have tissue-
dependent expression levels and activities and may
contribute to the observed differences in mRNA stability
(34–38).
One of the new aspects of the current study is the notion
that also splice variants that share the same 30-UTR but
include alternative internal exons may differ in stability. It
was previously thought that the splicing machinery deter-
mines the abundance of the different splice isoforms aided
by tissue-speciﬁc splicing factors like FOX, CELF, PTB,
MBNL, hnRNP A/B (26,39,40). From our study, it
appears that the presence of stabilizing or destabilizing
elements in the alternative exons or differences in struc-
tural characteristics of the synthesized transcripts may
also contribute to their differential expression. We show
this in detail for the Itga7 transcripts variants with or
without exon 23. The transcript including exon 23
appears to be me far more stable in differentiated cells,
whereas in proliferating cells it is subject to fast degrad-
ation. A comparison of the nuclear fraction of the RNA
with total RNA (nuclear and cytoplasmic) shows that the
degradation of the transcript containing exon 23 mainly
occurs in the cytoplasm. This observation is in line with a
recent publication showing major differences between
transcript variants in their nucleocytoplasmic distribution,
at least partly attributable to mechanistic differences
between nuclear and cytoplasmic mRNA degradation
(41). We investigated whether exon 23 contains any
known destabilizing elements such as AREs or PUFs
(7), but could not ﬁnd any. It is still possible that exon
23 contains an miRNA binding site but prediction
programs failed to predict a good candidate. Thus, the
mechanism for its preferential cytoplasmic degradation
in proliferating myoblast remains elusive.
We conclude that mRNA degradation is a key
controlling factor in gene expression regulation, possibly
as important as transcription factor-mediated induction of
mRNA synthesis. The mechanisms of mRNA degradation
are currently less well understood than the mechanisms
behind transcription factor activity regulation. We have
gained several mechanistic insights in the process of
mRNA degradation, but many mechanistic aspects
deserve more attention in future studies. Knowledge on
mRNA degradation rates, as presented in this study, is
important for the proper interpretation of many biological
studies. Decay rates need to be taken into account when
choosing a time point for evaluation of the perturbation of
a biological system, aid the modeling of transcriptional
networks, and should be incorporated as important par-
ameters in systems biology approaches.
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